ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$148,000
-65.5%
286,500
-51.0%
0.00%
-100.0%
Q2 2020$429,000
+46.4%
584,200
+306.4%
0.00%0.0%
Q4 2019$293,000
+2.4%
143,735
+567.4%
0.00%0.0%
Q1 2019$286,000
-29.4%
21,536
-17.2%
0.00%0.0%
Q4 2018$405,000
+30.6%
26,000
+65.0%
0.00%0.0%
Q3 2018$310,000
-60.0%
15,756
-41.7%
0.00%
-50.0%
Q2 2018$775,00027,0360.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders